NASDAQ:AKU

Akumin (AKU) Stock Forecast, Price & News

$0.15

0.00 (0.00%)

(As of 09/29/2023 ET)

Compare

Today's Range: $0.14
▼
$0.15
50-Day Range: $0.13
▼
$0.22
52-Week Range: $0.12
▼
$2.18

Volume: 148,763 shs
Average Volume: 616,257 shs
Market Capitalization: $13.28 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $0.25

Akumin MarketRank™ Forecast

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 71.4% Upside
$0.25 Price Target
Short Interest: Healthy
3.80% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.44
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($2.22) to ($1.00) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.35 out of 5 stars

Medical Sector

287th out of 973 stocks

Medical Laboratories Industry

8th out of 24 stocks

3.0

Analyst's Opinion

Consensus Rating
Akumin has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $0.25, Akumin has a forecasted upside of 71.4% from its current price of $0.15.
Amount of Analyst Coverage
Akumin has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
3.80% of the float of Akumin has been sold short.
Short Interest Ratio / Days to Cover
Akumin has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Akumin has recently decreased by 5.60%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Akumin does not currently pay a dividend.
Dividend Growth
Akumin does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AKU.

3.0

News and Social Media Coverage

News Sentiment
Akumin has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Akumin this week, compared to 0 articles on an average week.
MarketBeat Follows
Only 1 people have added Akumin to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Akumin insiders have not sold or bought any company stock.
Percentage Held by Insiders
20.51% of the stock of Akumin is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 36.10% of the stock of Akumin is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Akumin are expected to grow in the coming year, from ($2.22) to ($1.00) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Akumin is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Akumin is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Akumin has a P/B Ratio of 0.12. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Akumin (NASDAQ:AKU) Stock

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.

AKU Price History

30 days | 90 days | 365 days | Advanced Chart

AKU Stock News Headlines

September 14, 2023 | ca.finance.yahoo.com

Akumin Inc. (AKU) Interactive Stock Chart - Yahoo Finance

August 10, 2023 | finanznachrichten.de

Akumin Inc.: Akumin Announces Second Quarter 2023 Results, Revised FY23 Financial Outlook and Establishment of Special Committee

September 29, 2023 | Chaikin Analytics (Ad)

Buy This Stock for AI Tidal Wave (not NVDA)

The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.

August 7, 2023 | finance.yahoo.com

15 Worst Performing Tech Stocks in 2023

August 2, 2023 | theglobeandmail.com

Closing Bell: Akumin Inc down on Tuesday (AKU)

June 19, 2023 | benzinga.com

Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, Phathom, and Akumin and Encourages Investors to Contact the Firm

June 12, 2023 | msn.com

Akumin appoints Krishna Kumar as President and COO

June 12, 2023 | marketwatch.com

Akumin Appoints Krishna Kumar to COO Role

September 29, 2023 | Chaikin Analytics (Ad)

Buy This Stock for AI Tidal Wave (not NVDA)

The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.

June 12, 2023 | finance.yahoo.com

Akumin appoints President and Chief Operating Officer

May 26, 2023 | benzinga.com

AKUMIN ALERT: Bragar Eagel & Squire, P.C. is Investigating Akumin Inc. on Behalf of Akumin Stockholders and Encourages Investors to Contact the Firm

May 25, 2023 | benzinga.com

Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Akumin Inc. (AKU)

May 17, 2023 | theglobeandmail.com

Closing Bell: Akumin Inc flat on Tuesday (AKU)

May 12, 2023 | marketwatch.com

Friday Sector Laggards: Diagnostics, Auto Dealerships

May 12, 2023 | msn.com

Akumin GAAP EPS of -$0.39, revenue of $187.59M in-line

May 12, 2023 | finance.yahoo.com

Q1 2023 Akumin Inc Earnings Call

May 11, 2023 | marketwatch.com

10-Q: AKUMIN INC.

May 11, 2023 | finanznachrichten.de

Akumin Inc.: Akumin Announces First Quarter 2023 Results

May 10, 2023 | finance.yahoo.com

Akumin Announces First Quarter 2023 Results

May 4, 2023 | finance.yahoo.com

Akumin to Host First Quarter 2023 Financial Results Call on May 11, 2023

April 22, 2023 | theglobeandmail.com

Closing Bell: Akumin Inc up on Friday (AKU)

April 18, 2023 | theglobeandmail.com

Closing Bell: Akumin Inc flat on Monday (AKU)

April 15, 2023 | theglobeandmail.com

Closing Bell: Akumin Inc flat on Friday (AKU)

April 13, 2023 | theglobeandmail.com

Closing Bell: Akumin Inc flat on Thursday (AKU)

April 13, 2023 | theglobeandmail.com

Closing Bell: Akumin Inc up on Wednesday (AKU)

March 17, 2023 | finanznachrichten.de

Akumin Inc.: Akumin Announces Full-Year 2022 Results and Provides 2023 Guidance

March 15, 2023 | markets.businessinsider.com

Akumin earnings: here's what Wall Street expects

See More Headlines

Receive AKU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akumin and its competitors with MarketBeat's FREE daily newsletter.

AKU Company Calendar

Last Earnings: 8/09/2023
Today: 9/29/2023
Next Earnings (Estimated): 11/08/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical laboratories
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:AKU
CUSIP: N/A
CIK: 1776197
Web: www.akumin.com
Phone: (844) 730-0050
Fax: N/A
Employees: 3,631
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $0.25
High Stock Price Forecast: $0.25
Low Stock Price Forecast: $0.25
Forecasted Upside/Downside: +71.4%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2.52)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-156,760,000.00
Net Margins: -30.56%
Pretax Margin: -28.78%
Return on Equity: -167.86%
Return on Assets: -7.81%

Debt

Debt-to-Equity Ratio: 17.02
Current Ratio: 0.99
Quick Ratio: 0.99

Sales & Book Value

Annual Sales: $749.63 million
Price / Sales: 0.02
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.24 per share
Price / Book: 0.12

Miscellaneous

Outstanding Shares: 91,000,000
Free Float: 72,334,000
Market Cap: $13.28 million
Optionable: Not Optionable
Beta: -0.68

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Mr. Riadh Zine-El-Abidine (Age 51)
Chairman & CEO
Comp: $1.78M

Mr. David Krestchmer (Age 65)
Chief Financial Officer
Comp: $580.51k

Mr. Rohit Navani (Age 46)
Chief Corp. Affairs Officer
Comp: $1.15M

Mr. Krishna Kumar Ananthasubramanian
Pres & COO

Mr. Paul Nelis (Age 55)
Chief Information Officer

Darren Speed
Chief Compliance Officer

Ms. Tracy Wiese (Age 54)
Chief Strategy & Marketing Officer

Ms. Holly Huso (Age 58)
Enterprise Sales Officer

Ms. Laurie R. Miller (Age 56)
Chief HR Officer

Mr. Mohammad Saleem
Sr. VP of Financial Reporting

Key Competitors

View All Competitors

Institutional Ownership

BlackRock Inc.
Sold 124,703 shares on 8/11/2023
Ownership: 0.628%

View All Institutional Transactions

AKU Stock - Frequently Asked Questions

Should I buy or sell Akumin stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Akumin in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" AKU shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AKU, but not buy additional shares or sell existing shares.
View AKU analyst ratings or view top-rated stocks.
What is Akumin's stock price forecast for 2023?: 2 brokerages have issued 1 year price objectives for Akumin's stock. Their AKU share price forecasts range from $0.25 to $0.25. On average, they predict the company's share price to reach $0.25 in the next year. This suggests a possible upside of 71.4% from the stock's current price.
View analysts price targets for AKU or view top-rated stocks among Wall Street analysts.
How have AKU shares performed in 2023?: Akumin's stock was trading at $0.7188 at the start of the year. Since then, AKU stock has decreased by 79.7% and is now trading at $0.1459.
View the best growth stocks for 2023 here.
Are investors shorting Akumin?: Akumin saw a decrease in short interest in September. As of September 15th, there was short interest totaling 2,190,000 shares, a decrease of 5.6% from the August 31st total of 2,320,000 shares. Based on an average daily volume of 1,650,000 shares, the days-to-cover ratio is presently 1.3 days. Currently, 3.8% of the shares of the stock are sold short.
View Akumin's Short Interest.
When is Akumin's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our AKU earnings forecast.
How were Akumin's earnings last quarter?: Akumin Inc. (NASDAQ:AKU) issued its quarterly earnings results on Wednesday, August, 9th. The company reported ($0.60) earnings per share (EPS) for the quarter. The firm earned $184.84 million during the quarter, compared to the consensus estimate of $193.50 million. Akumin had a negative net margin of 30.56% and a negative trailing twelve-month return on equity of 167.86%.

What guidance has Akumin issued on next quarter's earnings?: Akumin issued an update on its FY 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $740.00 million-$750.00 million, compared to the consensus revenue estimate of $781.75 million.
What is Akumin's stock symbol?: Akumin trades on the NASDAQ under the ticker symbol "AKU."
How do I buy shares of Akumin?: Shares of AKU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Akumin's stock price today?: One share of AKU stock can currently be purchased for approximately $0.15.
How much money does Akumin make?: Akumin (NASDAQ:AKU) has a market capitalization of $13.28 million and generates $749.63 million in revenue each year. The company earns $-156,760,000.00 in net income (profit) each year or ($2.52) on an earnings per share basis.
How many employees does Akumin have?: The company employs 3,631 workers across the globe.
How can I contact Akumin?: The official website for the company is www.akumin.com. The company can be reached via phone at (844) 730-0050.

This page (NASDAQ:AKU) was last updated on 9/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial